Hudson Frederick M.
Insider CIK 1438462 · ARDM Director · SUPN Director · SCPH Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SUPN SUPERNUS PHARMACEUTICALS, | S Sale | 2026-03-12 | 2026-03-16 | 5,369 | $50.61 | $271.7K | 60,413 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | D To issuer deriv | 2026-02-24 | 2026-02-25 | 4,475 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award | 2026-02-24 | 2026-02-25 | 4,475 | — | $0 | 65,782 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2026-02-18 | 2026-02-20 | 4,977 | — | $0 | 4,977 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2026-02-18 | 2026-02-20 | 2,989 | — | $0 | 2,989 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise deriv | 2026-01-09 | 2026-01-12 | 15,000 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise | 2026-01-09 | 2026-01-12 | 15,000 | $12.98 | $194.7K | 61,307 | SEC↗ |
| SCPH scPharmaceuticals Inc. | D To issuer deriv | 2025-10-07 | 2025-10-07 | 6,124 | — | $0 | 0 | SEC↗ |
| SCPH scPharmaceuticals Inc. | D To issuer deriv | 2025-10-07 | 2025-10-07 | 16,300 | — | $0 | 0 | SEC↗ |
| SCPH scPharmaceuticals Inc. | D To issuer deriv | 2025-10-07 | 2025-10-07 | 30,000 | — | $0 | 0 | SEC↗ |
| SCPH scPharmaceuticals Inc. | D To issuer deriv | 2025-10-07 | 2025-10-07 | 19,750 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | S Sale | 2025-08-14 | 2025-08-18 | 7,457 | $42.26 | $315.1K | 46,307 | SEC↗ |
| SCPH scPharmaceuticals Inc. | A Award deriv | 2025-06-03 | 2025-06-05 | 30,000 | — | $0 | 30,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | D To issuer deriv | 2025-02-22 | 2025-02-24 | 5,369 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award | 2025-02-22 | 2025-02-24 | 5,369 | — | $0 | 53,764 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2025-02-19 | 2025-02-21 | 4,475 | — | $0 | 4,475 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2025-02-19 | 2025-02-21 | 7,296 | — | $0 | 7,296 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise deriv | 2025-01-22 | 2025-01-23 | 20,000 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise | 2025-01-22 | 2025-01-23 | 20,000 | $9.13 | $182.6K | 48,395 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | S Sale | 2024-11-08 | 2024-11-12 | 8,722 | $36.28 | $316.4K | 28,395 | SEC↗ |
| SCPH scPharmaceuticals Inc. | A Award deriv | 2024-06-11 | 2024-06-13 | 19,750 | — | $0 | 19,750 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | D To issuer deriv | 2024-02-23 | 2024-02-27 | 3,886 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award | 2024-02-23 | 2024-02-27 | 3,886 | — | $0 | 37,117 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2024-02-22 | 2024-02-26 | 8,252 | — | $0 | 8,252 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2024-02-22 | 2024-02-26 | 5,369 | — | $0 | 5,369 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise deriv | 2023-11-15 | 2023-11-17 | 7,457 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise | 2023-11-15 | 2023-11-17 | 7,457 | $9.24 | $68.9K | 42,324 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | S Sale | 2023-11-15 | 2023-11-17 | 5,211 | $28.50 | $148.5K | 33,231 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | S Sale | 2023-11-15 | 2023-11-17 | 3,882 | $28.50 | $110.6K | 38,442 | SEC↗ |
| SCPH scPharmaceuticals Inc. | A Award deriv | 2023-06-06 | 2023-06-08 | 17,300 | — | $0 | 17,300 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2023-02-23 | 2023-02-27 | 6,293 | — | $0 | 6,293 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2023-02-23 | 2023-02-27 | 3,886 | — | $0 | 3,886 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | D To issuer deriv | 2023-02-22 | 2023-02-24 | 3,882 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award | 2023-02-22 | 2023-02-24 | 3,882 | — | $0 | 34,867 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise deriv | 2023-01-10 | 2023-01-12 | 8,722 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise | 2023-01-10 | 2023-01-12 | 8,722 | $7.90 | $68.9K | 30,985 | SEC↗ |
| SCPH scPharmaceuticals Inc. | A Award deriv | 2022-06-14 | 2022-06-15 | 16,300 | — | $0 | 16,300 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2022-02-22 | 2022-02-24 | 3,882 | — | $0 | 3,882 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2022-02-22 | 2022-02-24 | 6,847 | — | $0 | 6,847 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | D To issuer deriv | 2022-02-19 | 2022-02-23 | 4,222 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award | 2022-02-19 | 2022-02-23 | 4,222 | — | $0 | 22,263 | SEC↗ |
| SCPH scPharmaceuticals Inc. | A Award deriv | 2021-06-08 | 2021-06-10 | 16,300 | — | $0 | 16,300 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2021-02-19 | 2021-02-23 | 7,365 | — | $0 | 7,365 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2021-02-19 | 2021-02-23 | 4,222 | — | $0 | 4,222 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise deriv | 2020-07-13 | 2020-07-15 | 8,750 | — | $0 | 0 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | M Exercise | 2020-07-13 | 2020-07-15 | 8,750 | $2.56 | $22.4K | 18,961 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | S Sale | 2020-07-13 | 2020-07-15 | 920 | $24.44 | $22.5K | 18,041 | SEC↗ |
| SCPH scPharmaceuticals Inc. | A Award deriv | 2020-06-09 | 2020-06-11 | 6,124 | — | $0 | 6,124 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award deriv | 2020-02-21 | 2020-02-25 | 9,305 | — | $0 | 9,305 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS, | A Award | 2020-02-21 | 2020-02-25 | 5,211 | $23.99 | $125.0K | 10,211 | SEC↗ |
| SCPH scPharmaceuticals Inc. | A Award deriv | 2019-06-18 | 2019-06-20 | 6,124 | — | $0 | 6,124 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2019-02-22 | 2019-02-26 | 12,427 | — | $0 | 12,427 | SEC↗ |
| ARDM ARADIGM CORP | A Award deriv | 2018-06-29 | 2018-07-03 | 97,323 | — | $0 | 97,323 | SEC↗ |
| SCPH scPharmaceuticals Inc. | A Award deriv | 2018-06-19 | 2018-06-21 | 12,248 | — | $0 | 12,248 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2018-02-23 | 2018-02-27 | 8,613 | — | $0 | 8,613 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2017-06-13 | 2017-06-15 | 6,036 | — | $0 | 6,036 | SEC↗ |
| ARDM ARADIGM CORP | A Award deriv | 2017-06-01 | 2017-06-05 | 110,485 | — | $0 | 110,485 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2017-02-24 | 2017-02-27 | 7,905 | — | $0 | 7,905 | SEC↗ |
| ARDM ARADIGM CORP | A Award deriv | 2016-06-09 | 2016-06-13 | 35,941 | — | $0 | 35,941 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2016-03-01 | 2016-03-03 | 15,000 | — | $0 | 15,000 | SEC↗ |
| ARDM ARADIGM CORP | A Award deriv | 2015-11-12 | 2015-11-16 | 19,940 | — | $0 | 19,940 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2015-03-03 | 2015-03-05 | 20,000 | — | $0 | 20,000 | SEC↗ |
| ARDM ARADIGM CORP | A Award deriv | 2014-04-18 | 2014-04-22 | 200,000 | — | $0 | 200,000 | SEC↗ |
| ARDM ARADIGM CORP | A Award deriv | 2014-04-18 | 2014-04-22 | 225,000 | — | $0 | 225,000 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2014-01-21 | 2014-01-23 | 7,457 | — | $0 | 7,457 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | A Award deriv | 2013-02-05 | 2013-02-07 | 8,722 | — | $0 | 8,722 | SEC↗ |
| SUPN SUPERNUS PHARMACEUTICALS I | P Buy | 2012-05-04 | 2012-05-07 | 5,000 | $5.00 | $25.0K | 5,000 | SEC↗ |